speb/financial-data huggingface dataset:
Financial scorecard for OLMA (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 11.7
Market cap: 1021965376 (USD: 1021965376)
P/B ratio: 2.7105315802388454
Debt to equity: 0.008199999999999999
Current ratio: 10.88
Return on net tangible assets (%): -11.02443816366202
Buffett classification: The Gruesome
Analyst consensus upside (%): 172.97116029510397
Rule of 40 score: 0
Altman Z-score: 11.199508035041223 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.023190609541746354
Total shareholder yield (%): 0.023190609541746354 (Low Return)
Momentum (%): 1m 5.026929982046667, 3m -24.661944623309726, 6m -53.62663495838288, 12m 156.0175054704595, composite 21.82503218903463 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.013348683128538872
FCF conversion rate: 0.866224641639511
Beneish M-score: -2.5255080892179675 (Likely Safe)
ROE (%): -11.071314245435786
Asset turnover: 0
Equity multiplier (leverage): 1.109524450047287
ROE archetype: Low Return
Treasury beta 1y: -0.004112688747270709 (R-squared: 0.000125907215044356)
Insider 90-day net shares: -855501 (net value USD: -24448182.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 31.046931407942242, ROIC , revenue growth 1y , 6m momentum 68.14079422382672
Sector percentiles: P/E , 6m momentum 71.88395415472779
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -161961000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ORCHASP.NS (Technology — Software - Application, India)
Report date: 2026-03-31 (annual)
Stock price: 0.016308835672997523
Market cap: 547352128 (USD: 5800679.610004239)
P/E ratio: 0.7280016881198564
P/B ratio: 0.5861031009800475
Debt to equity: 0.0602
Current ratio: 1.48
Return on net tangible assets (%): 0.8796799193394107
Buffett classification: The Gruesome
Rule of 40 score: -28.446187426563554
Altman Z-score: 0.522927154013569 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -22.77238908677092, 3m -25.13051096654649, 6m -43.863270893998, 12m -52.23446094416997, composite -35.71448099477949 (Strong Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 2, short score 14, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -8.601153977499287
Revenue CAGR 3y (%): -7.615977584621492
Net income CAGR 3y (%): 37.76099936894028
FCF CAGR 3y (%): nan
Revenue deceleration: yes
Revenue growth consistency score: 46.37163567543085
Beneish M-score: -2.50493774156373 (Likely Safe)
ROE (%): 0.8569249107488427
Net margin (%): 4.949144249677741
Asset turnover: 0.09360248017742415
Equity multiplier (leverage): 1.8498022333659816
ROE archetype: Low Return
P/E z-score: 1.0106735038653283
Treasury beta 1y: 0.0005505935012521677 (R-squared: 1.9789411903196382e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -2.3590311527594965 (pretax: -2.372037218050376)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 25.471698113207548, P/B 9.568733153638814, ROIC 51.21293800539084, revenue growth 1y 50, 6m momentum 80.18867924528303
Sector percentiles: P/E 25.492158825492155, 6m momentum 74.9416082749416
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05
Base cash flow: 113543.874523103
DCF price per share: base 0.0001793478251137917, conservative 0.0001428553924658523, aggressive 0.00023489912425797083
Financial scorecard for ORD.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.36111111111111116
Market cap: 39298680 (USD: 25685411.76470588)
Debt to equity: 0.0223
Current ratio: 5.97
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 4.722222222222229, 3m -38.34688346883468, 6m -40.08838383838383, 12m 47.37237237237239, composite -12.5694444922788 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.014605267257835015 (R-squared: 0.003931811432631378)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 56.798866855524075
Sector percentiles: P/E , 6m momentum 63.7423653525819
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OZM.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.0625
Market cap: 24957364 (USD: 16312002.614379086)
P/B ratio: 6.199320291671956
Debt to equity: 0.0558
Current ratio: 2.43
Interest coverage ratio: -120.78518205358559
Return on net tangible assets (%): -66.40358736731086
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 0 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.7765122951286041
Debt paydown yield (%): 0.151932231304556
Total shareholder yield (%): 0.9284445264331601 (Low Return)
Momentum (%): 1m 13.281249999999986, 3m -12.50000000000001, 6m 30.357142857142843, 12m 34.82142857142857, composite 12.290640394088664 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.1352406836847295
ROE archetype: Standard Business
Treasury beta 1y: -0.022816817196265642 (R-squared: 0.004579531328819428)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -119.50761864798281 (pretax: -151.27546664301622)
Incremental ROIC 3y (%): 1328.9657831545019 (pretax: 1682.235168550002)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 49.71671388101983, ROIC 51.69971671388102, revenue growth 1y , 6m momentum 4.53257790368272
Sector percentiles: P/E , 6m momentum 7.634647418101055
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10466492711268012
Base cash flow: -1422179.08496732
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for P1E.AX (Energy — Oil & Gas E&P, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.020833333333333332
Market cap: 13009131 (USD: 8502700)
P/B ratio: 2.342757320326007
Debt to equity: 0.1066
Current ratio: 1.23
Return on net tangible assets (%): -130.32399869749267
Buffett classification: The Gruesome
Analyst consensus upside (%): 1123.9999999999998
Rule of 40 score: -19.019335509014695
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -24.47916666666668, 3m -51.38888888888889, 6m -61.979166666666664, 12m -71.40151515151516, composite -58.49990566585394 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.9500288136988557
ROE archetype: Standard Business
Treasury beta 1y: 0.0010746469731939036 (R-squared: 1.6318070701927117e-05)
Insider 90-day net shares: 200000 (net value USD: 4980.00)
ROIC (%): -33.28013219284603 (pretax: -42.12674961119751)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 45.94594594594595, ROIC 65.09009009009009, revenue growth 1y , 6m momentum 75.45045045045045
Sector percentiles: P/E , 6m momentum 77.89890981169475
Industry median P/E: 11.260253542132737; industry median ROIC: 0.8337488598897688
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.08230812867598038
Base cash flow: -10463398.692810457
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PBYI (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.98
Market cap: 406177664 (USD: 406177664)
P/E ratio: 13.3125
P/B ratio: 2.532764794418141
Debt to equity: 0.1242
Current ratio: 2.38
Interest coverage ratio: -5.236662106703147
Return on net tangible assets (%): -1.3067438714942041
Buffett classification: The Gruesome
Analyst consensus upside (%): -21.752738654147098
Rule of 40 score: -10.437591747469781
Altman Z-score: -4.882122260832836 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 42.87586357523019, earnings yield % 11.634607773568717, rank 270
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.100121231678559
Total shareholder yield (%): 3.100121231678559 (Low Return)
Momentum (%): 1m 0.37735849056604087, 3m 5.835543766578255, 6m 24.299065420560755, 12m 134.7058823529412, composite 54.65271286630125 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue growth 1y (%): -2.593083661181994
Net income growth 1y (%): -226.1936785474109
Revenue deceleration: no
Accrual ratio: -0.09373571213762313
FCF conversion rate: -4.107647215560885
Beneish M-score: -3.56854181400138 (Likely Safe)
ROE (%): -2.900802300236516
Net margin (%): -8.374615075646004
Asset turnover: 0.21913882851142175
Equity multiplier (leverage): 1.5806435406328743
ROE archetype: Low Return
P/E z-score: 4.661179752847446
FCF z-score: 3.9180314430961958
Treasury beta 1y: -0.0028716740420394985 (R-squared: 0.0003256748513052865)
Insider 90-day net shares: -141414 (net value USD: -1084258.00)
ROIC (%): 52.85369482178306 (pretax: 60.78913915055901)
Incremental ROIC 3y (%): 190.4626328710018 (pretax: 100.55020632737278)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 8.754512635379061, P/B 29.061371841155236, ROIC 1.444043321299639, revenue growth 1y 18.95306859205776, 6m momentum 14.350180505415164
Sector percentiles: P/E 20.845272206303726, 6m momentum 12.607449856733524
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12004594132446497
Base cash flow: 41978000
DCF price per share: base 9.95413830700124, conservative 9.222845533804971, aggressive 10.788951886343435
Financial scorecard for PESO.V (Consumer Defensive — Discount Stores, Canada)
Report date: 2026-04-30 (quarterly)
Stock price: 0.3262411347517731
Market cap: 94816848 (USD: 69209378.10218978)
Debt to equity: -18.99859985556776
Current ratio: 0.64
Interest coverage ratio: -1.9228570563912408
Buffett classification: The Gruesome
Rule of 40 score: -42.96952304339398
Altman Z-score: -1.4029122889613839 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.760151958866435
Total shareholder yield (%): -1.760151958866435 (Minimal or Negative)
Momentum (%): 1m -14.210664565274497, 3m -22.93959403277083, 6m 40.69148936170212, 12m 160.99290780141845, composite 73.99241581386913 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue growth 1y (%): 16.081819533031872
Revenue deceleration: no
Revenue growth consistency score: 30.408244064995785
Accrual ratio: -0.040833459909333264
FCF conversion rate: 0.5757797693084128
Beneish M-score: -2.4495398384733993 (Likely Safe)
Net margin (%): -51.34161978629207
Asset turnover: 0.18748012664822256
ROE archetype: Standard Business
Treasury beta 1y: 0.015386002704868609 (R-squared: 0.0061583951095506104)
Insider 90-day net shares: -19500 (net value USD: -15026.00)
ROIC (%): -32.478605137141756 (pretax: -41.11215840144526)
Incremental ROIC 3y (%): 3.4014982634889215 (pretax: 4.3056940044163685)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 84.84848484848484, revenue growth 1y 9.090909090909092, 6m momentum 0
Sector percentiles: P/E , 6m momentum 3.258508327299059
Industry median P/E: 17.960177849712736; industry median ROIC: 12.316287845972834
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.1044671195409897
Base cash flow: -9677209.629629629
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PRN.L (Consumer Defensive — Packaged Foods, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.04346666666666666
Market cap: 796508160 (USD: 1076362378.3783784)
P/E ratio: 0.1643535427319211
P/B ratio: 0.010232452246345296
Debt to equity: 0.24719276530737405
Current ratio: 2
Interest coverage ratio: 1.9587479215603474
Return on net tangible assets (%): 3.8106482772937538
Buffett classification: The Gruesome
Analyst consensus upside (%): 967458.2222222224
Rule of 40 score: 5.099997983822729
Altman Z-score: 2.2395368045578246 (Grey Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 6.575572344586039, earnings yield % 12.854951869840784, rank 2617
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 43.251597070895045
Total shareholder yield (%): 43.251597070895045 (High Return)
Momentum (%): 1m 4.871957671957664, 3m -13.76586237712244, 6m -28.521481481481487, 12m , composite -21.143671929301963 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 9, short score 3, recommendation: Long
Revenue growth 1y (%): -1.4737109208120325
Net income growth 1y (%): 333.3657062695586
Revenue CAGR 3y (%): 5.495671700341931
Revenue deceleration: yes
Revenue growth consistency score: 11.124420843122909
Accrual ratio: -0.056016215749017335
FCF conversion rate: 3.3118606654463227
Beneish M-score: -2.098436351552782 (Likely Safe)
Equity multiplier (leverage): 2.581841198980191
ROE archetype: Standard Business
P/E z-score: 1.9539177787281978
FCF z-score: 1.6557244982272172
Treasury beta 1y: 0.0007400905490545636 (R-squared: 0.00012081667975711491)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 5.806921204915651 (pretax: 8.660203555333583)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 21.779859484777518, P/B 0.468384074941452, ROIC 44.49648711943794, revenue growth 1y 34.19203747072599, 6m momentum 68.38407494145198
Sector percentiles: P/E 18.609703113685736, 6m momentum 69.29761042722666
Industry median P/E: 0.5444598070416563; industry median ROIC: 6.765322712696236
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.09991113191808954
Base cash flow: 47627027.02702704
DCF price per share: base 0.08450473043876422, conservative 0.07157865380004226, aggressive 0.10158752973318666
Financial scorecard for PVT.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 18384416 (USD: 12015958.16993464)
Current ratio: 20.11
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -51.38888888888889, 6m -49.30555555555556, 12m 4.861111111111119, composite -32.18550446998723 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.005466840421986074 (R-squared: 3.555266192367596e-05)
Insider 90-day net shares: 1214112 (net value USD: 10927.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 61.78184845961698
Sector percentiles: P/E , 6m momentum 70.21099389228208
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.09035000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for QTWO (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 54.61
Market cap: 3418609152 (USD: 3418609152)
P/E ratio: 41.85840707964602
P/B ratio: 4.840798082481575
Debt to equity: 0.5622
Current ratio: 0.93
Interest coverage ratio: 23.341908713692945
Return on net tangible assets (%): 138.03960740033006
Buffett classification: The Great
Analyst consensus upside (%): 52.600422832980996
Rule of 40 score: 15.038185765474669
Altman Z-score: 2.785761385878352 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 178.17686557709362, earnings yield % 0.8312694452090168, rank 585
Dividend yield (%): 0
Buyback yield (%): 2.841886734643598
Debt paydown yield (%): 0.08538560186947045
Total shareholder yield (%): 2.9272723365130684 (Low Return)
Momentum (%): 1m 21.274705751721072, 3m 10.41245450869389, 6m -20.254088785046733, 12m -38.921820825411025, composite -19.82604675334119 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 10, short score 4, recommendation: Neutral
Revenue growth 1y (%): 14.109679289535414
Net income growth 1y (%): 460.46707342730906
Revenue deceleration: no
Accrual ratio: -0.013930732443677695
FCF conversion rate: 1.6595968317129022
Beneish M-score: -2.3085608532636925 (Likely Safe)
ROE (%): 4.183631242407658
Net margin (%): 12.3040470010069
Asset turnover: 0.17165142327988633
Equity multiplier (leverage): 1.980879270852392
ROE archetype: Low Return
P/E z-score: 1.7924408092912638
FCF z-score: 5.06562372904126
Treasury beta 1y: 0.0030425195034114298 (R-squared: 0.0008312388422007977)
Insider 90-day net shares: -24894 (net value USD: -1208768.00)
ROIC (%): 7.242109526164935 (pretax: 7.620451542443011)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 49.73045822102426, P/B 53.77358490566038, ROIC 38.00539083557952, revenue growth 1y 25.60646900269542, 6m momentum 51.078167115902964
Sector percentiles: P/E 47.51418084751418, 6m momentum 55.021688355021695
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.11254693631739057
Base cash flow: 98622000
DCF price per share: base 37.44644605460742, conservative 24.268126959322057, aggressive 58.897814503211045
Financial scorecard for QUBE.L (Industrials — Security & Protection Services, United Kingdom)
Report date: 2025-10-31 (quarterly)
Stock price: 0.0028
Market cap: 17717104 (USD: 23311978.94736842)
P/B ratio: 0.06563216435643565
Debt to equity: 0.0417
Current ratio: 1.94
Buffett classification: The Gruesome
Analyst consensus upside (%): 1837718.1818181816
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.6431449895347833
Total shareholder yield (%): -0.6431449895347833 (Minimal or Negative)
Momentum (%): 1m -3.2727272727272787, 3m -9.913043478260867, 6m -13.666666666666663, 12m -13.666666666666663, composite -11.441774726671747 (Moderate Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6909422098536493 (Likely Safe)
Equity multiplier (leverage): 1.1942568611694895
ROE archetype: Standard Business
Treasury beta 1y: 0.0002498815260515356 (R-squared: 4.283922883785169e-06)
Insider 90-day net shares: 67733 (net value USD: 21877.00)
ROIC (%): -225.7079843662759 (pretax: -285.70630932439985)
Incremental ROIC 3y (%): -237.55021205400575 (pretax: -300.69647095443764)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 9.090909090909092, ROIC 72.72727272727273, revenue growth 1y , 6m momentum 56.81818181818182
Sector percentiles: P/E , 6m momentum 61.776753712237586
Industry median P/E: 1.3143710092047434; industry median ROIC: 5.759044132648424
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.1008170675664549
Base cash flow: -6264000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for QUCY (Healthcare — Diagnostics & Research, Germany)
Report date: 2026-03-31 (quarterly)
Stock price: 1.1
Market cap: 24588636 (USD: 24588636)
P/B ratio: 2.028532976459114
Debt to equity: 0.0276
Current ratio: 2.11
Interest coverage ratio: -162.30925864909392
Return on net tangible assets (%): -144.55784857192504
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -16.36085550571837 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 11.711018411021417
Total shareholder yield (%): 11.711018411021417 (High Return)
Momentum (%): 1m -25.170068027210878, 3m 115.68627450980394, 6m -6.77966101694914, 12m -44.723618090452256, composite 27.59198674217438 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.26169156427668144
FCF conversion rate: 0.6608939189473713
Beneish M-score: -2.2803423537313794 (Likely Safe)
ROE (%): -193.747356803861
Asset turnover: 0
Equity multiplier (leverage): 2.5106237972041914
ROE archetype: Low Return
Treasury beta 1y: -0.015801878698387888 (R-squared: 0.00036876051848685045)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -440.7261379811259 (pretax: -557.881187317881)
Incremental ROIC 3y (%): 400.56426283677445 (pretax: 507.04337067946136)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 33.088235294117645, ROIC 77.20588235294117, revenue growth 1y , 6m momentum 41.911764705882355
Sector percentiles: P/E , 6m momentum 36.96275071633238
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -18366584.70588235
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RENX.L (Healthcare — Health Information Services, United Kingdom)
Report date: 2025-12-31 (quarterly)
Stock price: 0.00039999999999999996
Market cap: 11580996 (USD: 15649994.594594594)
Debt to equity: -4.833333333333333
Current ratio: 1.57
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 15.45311819466996
Total shareholder yield (%): 15.45311819466996 (High Return)
Momentum (%): 1m 51.99999999999999, 3m 47.999999999999986, 6m -50.66666666666667, 12m -57.714285714285715, composite -24.949039264828745 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 5, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.154945862903036 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.00014438619907035879 (R-squared: 2.926596144894992e-07)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 72.10526315789474
Sector percentiles: P/E , 6m momentum 70.77363896848138
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.050151728802352635
Base cash flow: -27945205.479452055
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RIVN (Consumer Cyclical — Auto Manufacturers, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 15.84
Market cap: 22926317568 (USD: 22926317568)
P/B ratio: 4.904947820873787
Debt to equity: 1.1815
Current ratio: 2.1
Interest coverage ratio: -13.553846153846154
Return on net tangible assets (%): -13.490801726095844
Buffett classification: The Gruesome
Analyst consensus upside (%): 24.717607973421917
Rule of 40 score: -85.44403440155948
Altman Z-score: -1.0847797899233436 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.32713496084815286
Total shareholder yield (%): 0.32713496084815286 (Low Return)
Momentum (%): 1m 8.196721311475406, 3m -4.1162227602905554, 6m -0.6896551724137895, 12m 14.61649782923299, composite 0.3758506263875058 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 11.37096774193549
Revenue deceleration: no
Accrual ratio: 0.04529676598962092
FCF conversion rate: 2.5841346153846154
Beneish M-score: -2.457313693076138 (Likely Safe)
ROE (%): -9.220879973401308
Net margin (%): -30.123099203475746
Asset turnover: 0.09492387531360622
Equity multiplier (leverage): 3.224758949351657
ROE archetype: Low Return
Treasury beta 1y: -0.022068914910023888 (R-squared: 0.019041729038199954)
Insider 90-day net shares: 62813270 (net value USD: 998634535.00)
ROIC (%): -54.85473561882627 (pretax: -69.43637420104591)
Incremental ROIC 3y (%): 230.7223214285714 (pretax: 292.05357142857144)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 47.93388429752066, ROIC 62.8099173553719, revenue growth 1y 21.487603305785125, 6m momentum 17.355371900826448
Sector percentiles: P/E , 6m momentum 34.909596662030594
Industry median P/E: 2.363674312966383; industry median ROIC: 2.175802453713685
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.11550597046686539
Base cash flow: -4552000000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ROIV (Healthcare — Biotechnology, United Kingdom)
Report date: 2026-03-31 (annual)
Stock price: 35.01
Market cap: 25181655040 (USD: 25181655040)
P/B ratio: 2.8610924744747765
Debt to equity: 0.0203
Current ratio: 18.37
Return on net tangible assets (%): -6.728674705182038
Buffett classification: The Gruesome
Analyst consensus upside (%): 38.447653429602894
Rule of 40 score: -13445.565571704617
Altman Z-score: 28.283994401138294 (Safe Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.6694640743141809
Debt paydown yield (%): -0.044774183288848385
Total shareholder yield (%): 1.6246898910253325 (Low Return)
Momentum (%): 1m 2.940311673037342, 3m 27.72710689529368, 6m 55.048715677590785, 12m 207.6449912126537, composite 93.87782252136567 (Strong Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 5, short score 4, recommendation: Neutral
Revenue growth 1y (%): -66.27268302857541
Revenue deceleration: no
Accrual ratio: 0.09405142720518037
FCF conversion rate: -0.46403874696410896
Beneish M-score: -2.7352757604384528 (Likely Safe)
ROE (%): -5.758048043868114
Net margin (%): -3629.1888619854717
Asset turnover: 0.00149164551339645
Equity multiplier (leverage): 1.0636532922806319
ROE archetype: Low Return
Treasury beta 1y: -0.008460173071737843 (R-squared: 0.007770893282086512)
Insider 90-day net shares: -4704076 (net value USD: -159465672.00)
ROIC (%): -91.64023385922779 (pretax: -116.00029602433897)
Incremental ROIC 3y (%): -57.636288923723576 (pretax: -72.95732775154882)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 8.212996389891696, P/B 31.949458483754512, ROIC 24.27797833935018, revenue growth 1y 25.992779783393498, 6m momentum 7.581227436823104
Sector percentiles: P/E 19.91404011461318, 6m momentum 5.551575931232092
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10764240977659567
Base cash flow: -400831578.94736844
DCF price per share: base 0.9821311519697498, conservative 1.6036586681939444, aggressive 0.2618944096541513
Financial scorecard for ROMJ.V (Healthcare — Drug Manufacturers - Specialty & Generic, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3191489361702128
Market cap: 30410514 (USD: 21878067.62589928)
P/B ratio: 0.795275201498631
Debt to equity: 0.3226
Current ratio: 2.54
Interest coverage ratio: -11.817757009345794
Return on net tangible assets (%): -9.845628693702873
Buffett classification: The Gruesome
Analyst consensus upside (%): 226.22448979591834
Rule of 40 score: -22.14490814616603
Altman Z-score: -0.780527186763487 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.718278078977641
Total shareholder yield (%): -2.718278078977641 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560266, 3m -20.502901353965182, 6m -8.244680851063823, 12m 0.9401286491835819, composite -9.506099844082707 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 10.824395986854697
Revenue deceleration: no
Accrual ratio: -0.03847027797891292
FCF conversion rate: 0.06395348837209303
Beneish M-score: -3.3266868495266766 (Likely Safe)
ROE (%): -6.374932587688422
Net margin (%): -15.913953622853178
Asset turnover: 0.2582556355160486
Equity multiplier (leverage): 1.5511282278333651
ROE archetype: Low Return
P/E z-score: 1.622271752462635
Treasury beta 1y: 0.005959123161272774 (R-squared: 0.001783661308069465)
Insider 90-day net shares: -39000 (net value USD: -12349.00)
ROIC (%): 2.746661332418891 (pretax: 3.4767864967327733)
Incremental ROIC 3y (%): 29.334805185173767 (pretax: 37.13266479135919)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 15.542521994134898, ROIC 52.19941348973607, revenue growth 1y 24.34017595307918, 6m momentum 47.50733137829912
Sector percentiles: P/E , 6m momentum 38.35959885386819
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.061499099269516716
Base cash flow: -2923357.6642335765
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RUM (Communication Services — Internet Content & Information, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 5.71
Market cap: 1574497920 (USD: 1574497920)
P/B ratio: 5.626313282293339
Debt to equity: 0.0063
Current ratio: 4.7
Return on net tangible assets (%): -12.674099197855556
Buffett classification: The Gruesome
Analyst consensus upside (%): 331.37254901960785
Rule of 40 score: -100.64726228282426
Altman Z-score: 13.241940200830939 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.02145337861100509
Total shareholder yield (%): 0.02145337861100509 (Low Return)
Momentum (%): 1m -7.9032258064516165, 3m -12.423312883435578, 6m -7.305194805194808, 12m -41.25514403292181, composite -18.64749981939257 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 14, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 7.394531271420557
Revenue deceleration: no
Accrual ratio: -0.035160359285696566
FCF conversion rate: 0.6236268007295583
Beneish M-score: -3.6912626467940086 (Likely Safe)
ROE (%): -11.536147264806724
Net margin (%): -118.89478611690369
Asset turnover: 0.07857272289127952
Equity multiplier (leverage): 1.2348840402994887
ROE archetype: Low Return
Treasury beta 1y: -0.008932812211406682 (R-squared: 0.0029259079453651596)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -229.246931256389 (pretax: -290.18598893213795)
Incremental ROIC 3y (%): -171.39016075383645 (pretax: -216.94957057447652)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 61.57024793388429, ROIC 71.07438016528926, revenue growth 1y 23.96694214876033, 6m momentum 28.512396694214875
Sector percentiles: P/E , 6m momentum 38.07973962571196
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.10898832624682882
Base cash flow: -71332734
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RUN (Technology — Solar, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 9.94
Market cap: 2371179776 (USD: 2371179776)
P/E ratio: 6.366197183098592
P/B ratio: 0.6526149322605473
Debt to equity: 3.003
Current ratio: 1.45
Interest coverage ratio: -0.16484619785332438
Return on net tangible assets (%): -2.0246028291816756
Buffett classification: The Gruesome
Analyst consensus upside (%): 38.938053097345126
Rule of 40 score: -98.6697885781828
Altman Z-score: -0.08791822870520886 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -4.109135924074278
Total shareholder yield (%): -4.109135924074278 (Minimal or Negative)
Momentum (%): 1m -31.067961165048548, 3m -21.97802197802198, 6m -49.02564102564103, 12m -6.0491493383742965, composite -11.569588991139087 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 0, short score 16, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 43.22279091996168
Net income growth 1y (%): 235.21425286436983
Revenue deceleration: no
Accrual ratio: 0.025646244181548407
FCF conversion rate: -2.4707952566152085
Beneish M-score: -2.345223206435413 (Likely Safe)
ROE (%): 3.3729358136414938
Net margin (%): 23.211964039206293
Asset turnover: 0.031833389901804024
Equity multiplier (leverage): 4.564711128843214
ROE archetype: Low Return
P/E z-score: 2.0897201382065433
Treasury beta 1y: 0.002962079858924181 (R-squared: 0.0002021868019436079)
Insider 90-day net shares: -230545 (net value USD: -3171255.00)
ROIC (%): -0.5261639292391728 (pretax: -0.6660302901761681)
Incremental ROIC 3y (%): 15.488838075007289 (pretax: 19.606124145578846)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 30.555555555555557, P/B 19.444444444444446, ROIC 41.66666666666667, revenue growth 1y 20.833333333333336, 6m momentum 63.888888888888886
Sector percentiles: P/E 32.3656990323657, 6m momentum 77.27727727727728
Industry median P/E: 2.8170500105507488; industry median ROIC: 0.4760017097045983
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08104875788033541
Base cash flow: -1324813000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RVG.V (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.48936170212765956
Market cap: 219496304 (USD: 157911010.07194245)
P/B ratio: 5.26065636969125
Debt to equity: 0
Current ratio: 5.72
Return on net tangible assets (%): -11.332856030352282
Buffett classification: The Gruesome
Analyst consensus upside (%): 349.07692307692304
Rule of 40 score: 0
Altman Z-score: 49.82727167722628 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 10.300574130361356, 3m -20.18743667679837, 6m -20.550688360450575, 12m 23.246650906225376, composite -9.667011945123669 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.005216042068390541
FCF conversion rate: 0.9493731110519403
Beneish M-score: 5.408334873569697 (Strong Manipulation Signal)
ROE (%): -10.780781194171375
Asset turnover: 0
Equity multiplier (leverage): 1.0463823050780243
ROE archetype: Low Return
Treasury beta 1y: -0.0008545358125152185 (R-squared: 2.8074550693052864e-05)
Insider 90-day net shares: 9440000 (net value USD: 5887228.00)
ROIC (%): -116.25551579999734 (pretax: -147.1588807594903)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 46.317280453257794, ROIC 51.41643059490085, revenue growth 1y , 6m momentum 27.90368271954674
Sector percentiles: P/E , 6m momentum 44.752915047196
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1162
Base cash flow: -9061378.195488721
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SALT.L (Consumer Defensive — Packaged Foods, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0026666666666666666
Market cap: 11223528 (USD: 15166929.72972973)
P/B ratio: 1.1484540688372094
Debt to equity: 13.353499999999999
Current ratio: 2.92
Interest coverage ratio: -11.734545454545456
Buffett classification: The Gruesome
Rule of 40 score: 18.38889832316613
Altman Z-score: -4.068284384108497 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.8959896018044983
Total shareholder yield (%): -0.8959896018044983 (Minimal or Negative)
Momentum (%): 1m -45.22522522522523, 3m -63.4567901234568, 6m -65.38011695906432, 12m -67.65027322404372, composite -56.59245766713891 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 4, recommendation: Neutral
Revenue growth 1y (%): 198.23423423423426
Revenue CAGR 3y (%): 53.79022353915421
Revenue deceleration: no
Revenue growth consistency score: 779.9793685862077
Accrual ratio: 0.0392979274121936
FCF conversion rate: 1.037206639954207
Beneish M-score: -8.920790139535532 (Likely Safe)
Equity multiplier (leverage): 147.27309748027523
ROE archetype: Standard Business
Treasury beta 1y: -0.007524204293243152 (R-squared: 0.0029014238417568775)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -216.41171477079791 (pretax: -273.9388794567063)
Incremental ROIC 3y (%): -104.79345308788596 (pretax: -132.6499406175772)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 32.08430913348946, ROIC 77.98594847775175, revenue growth 1y 0.468384074941452, 6m momentum 79.62529274004683
Sector percentiles: P/E , 6m momentum 81.02824040550325
Industry median P/E: 0.5444598070416563; industry median ROIC: 6.765322712696236
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.07676994506944891
Base cash flow: -4810810.810810811
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SEER (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.97
Market cap: 108313656 (USD: 108313656)
P/B ratio: 0.3825136168362466
Debt to equity: 0.09539999999999998
Current ratio: 17.73
Return on net tangible assets (%): -6.451906791066718
Buffett classification: The Gruesome
Analyst consensus upside (%): 138.0952380952381
Rule of 40 score: -692.5425290009434
Altman Z-score: 0.19256270498767653 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 2.420747389415052
Debt paydown yield (%): 0.5761046418745204
Total shareholder yield (%): 2.9968520312895723 (Low Return)
Momentum (%): 1m 16.56804733727811, 3m 0, 6m 3.141361256544505, 12m -9.633027522935787, composite -6.445234321212996 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -34.716525934861274
Revenue deceleration: no
Accrual ratio: -0.00398440731061306
FCF conversion rate: 0.9327671200332601
Beneish M-score: -2.496654287176684 (Likely Safe)
ROE (%): -6.724229511208381
Net margin (%): -622.2099039172209
Asset turnover: 0.009524563765476095
Equity multiplier (leverage): 1.134646335959871
ROE archetype: Low Return
Treasury beta 1y: 0.008597153119153973 (R-squared: 0.004578257953386137)
Insider 90-day net shares: -17963 (net value USD: -35617.00)
ROIC (%): -63.47868372792648 (pretax: -80.35276421256516)
Incremental ROIC 3y (%): 36.689602741709706 (pretax: 46.44253511608824)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 3.9711191335740073, ROIC 21.3898916967509, revenue growth 1y 22.92418772563177, 6m momentum 25.361010830324908
Sector percentiles: P/E , 6m momentum 25.07163323782235
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11928359653215179
Base cash flow: -68647000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SEGN.V (Healthcare — Health Information Services, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.19858156028368798
Market cap: 12689329 (USD: 9129013.669064749)
Debt to equity: -0.7836363636363636
Current ratio: 0.34
Interest coverage ratio: -16.931034482758623
Buffett classification: The Gruesome
Rule of 40 score: -280.7712942874925
Altman Z-score: -45.09698044175421 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -7.6262135568173335
Total shareholder yield (%): -7.6262135568173335 (Minimal or Negative)
Momentum (%): 1m -11.879432624113461, 3m -22.269503546099266, 6m 24.56479690522245, 12m , composite 1.1476466795615927 (Moderate Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 20.533276349217665
Revenue deceleration: no
Revenue growth consistency score: 16.796110270499224
Accrual ratio: -0.1021310625493459
FCF conversion rate: 0.8950381679389312
Beneish M-score: -2.6470924197935948 (Likely Safe)
Net margin (%): -295.2112676056338
Asset turnover: 0.3296047927728889
ROE archetype: Standard Business
Treasury beta 1y: 0.0010030555804697156 (R-squared: 4.050951681480391e-06)
Insider 90-day net shares: -1136511 (net value USD: 4543.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 13.684210526315791, 6m momentum 10.526315789473683
Sector percentiles: P/E , 6m momentum 12.571633237822349
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10422647271560222
Base cash flow: -4488321.167883212
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SIGNATURE.NS (Real Estate — Real Estate - Development, India)
Report date: 2026-03-31 (annual)
Stock price: 7.930945499587119
Market cap: 108096110592 (USD: 1145571328.8681645)
P/E ratio: 0.0968180008929163
P/B ratio: 5.40837799103106
Debt to equity: 1.6103999999999998
Current ratio: 1.16
Interest coverage ratio: -1.3218457556248755
Return on net tangible assets (%): 60.310633576174325
Buffett classification: The Gruesome
Analyst consensus upside (%): 14914.574628955475
Rule of 40 score: -3.0378192495816223
Altman Z-score: 0.6409462096210194 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -3.2593370946171896, 3m -10.639774802018112, 6m -15.788313818601807, 12m -42.581390048238056, composite -22.35832004510694 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 4, recommendation: Neutral
Revenue growth 1y (%): -5.796398759687116
Net income growth 1y (%): 880.4717405733818
Revenue CAGR 3y (%): 13.481952817611242
Revenue deceleration: yes
Revenue growth consistency score: 66.01559275639372
Accrual ratio: 0.06330520848671305
FCF conversion rate: 0.09065778463135046
Beneish M-score: -1.8083118967099752 (Likely Safe)
ROE (%): 62.306200083478046
Net margin (%): 104.07688848027483
Asset turnover: 0.06417000049318475
Equity multiplier (leverage): 9.329211154051604
ROE archetype: Leverage-Driven Returns
P/E z-score: 3.483125883404808
FCF z-score: 3.4831258834048078
Treasury beta 1y: -0.054212139367070096 (R-squared: 0.002447919440900429)
Insider 90-day net shares: 17000 (net value USD: 247679.00)
ROIC (%): -3.34416605876663 (pretax: -4.002600572467594)
Incremental ROIC 3y (%): -19.458004332093413 (pretax: -23.811595403160858)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 12.213740458015266, P/B 77.48091603053436, ROIC 73.2824427480916, revenue growth 1y 34.35114503816794, 6m momentum 55.343511450381676
Sector percentiles: P/E 9.472049689440993, 6m momentum 59.161490683229815
Industry median P/E: 0.7477477477477478; industry median ROIC: 1.4222722989118621
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.09616853575898653
Base cash flow: 118027130.13988978
DCF price per share: base 0.26657893049703724, conservative 0.15470897356618002, aggressive 0.4630794130029567
Financial scorecard for SNM.AX (Basic Materials — Gold, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.3819444444444445
Market cap: 57279904 (USD: 38442888.59060403)
Debt to equity: 0.0046
Current ratio: 12.96
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -12.09215167548501, 3m -16.44965277777778, 6m 9.340958605664493, 12m , composite -3.5543470860566426 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.005898841971924853 (R-squared: 0.0012233144727576226)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 8.640226628895183
Sector percentiles: P/E , 6m momentum 15.13048306496391
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for SNWV (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 5.93
Market cap: 50991928 (USD: 50991928)
P/E ratio: 18.010416666666668
P/B ratio: 80.89025845484223
Debt to equity: 12.058800000000002
Current ratio: 1.31
Interest coverage ratio: -2.0586080586080584
Buffett classification: The Gruesome
Rule of 40 score: -40.8023097138601
Altman Z-score: -8.003109753118226 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 54.09100853204988, earnings yield % 7.927610670406852, rank 368
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.5826034269580864
Total shareholder yield (%): 1.5826034269580864 (Low Return)
Momentum (%): 1m -30.805134189031513, 3m -68.28877005347593, 6m -77.69838285069575, 12m -83.8683351468988, composite -74.22458959700174 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 9, recommendation: Short
Revenue growth 1y (%): 3.0643951569699013
Revenue deceleration: no
Accrual ratio: -0.04508328855454057
FCF conversion rate: -0.16608756080611536
Beneish M-score: -2.370283312767531 (Likely Safe)
ROE (%): -83.25137402371999
Net margin (%): -14.959975049381432
Asset turnover: 0.25843632455668997
Equity multiplier (leverage): 21.53312120335551
ROE archetype: Low Return
P/E z-score: 0.4754383545158477
FCF z-score: 1.295984894440682
Treasury beta 1y: -0.006718914381930747 (R-squared: 0.0009829727089969295)
Insider 90-day net shares: -122698 (net value USD: -2186193.00)
ROIC (%): 38.866756565993 (pretax: 39.14971102842213)
Incremental ROIC 3y (%): 75.74497421829925 (pretax: 87.8556075357188)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 14.836795252225517, P/B 68.24925816023739, ROIC 1.483679525222552, revenue growth 1y 37.68545994065282, 6m momentum 76.55786350148368
Sector percentiles: P/E 22.45702005730659, 6m momentum 77.82951289398281
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.13690953327639968
Base cash flow: 11154000
DCF price per share: base 25.862883658247096, conservative 15.377662498149542, aggressive 43.53477120607544